Influence of timing in the fructosamine assay.
The fructosamine assay, based on the measurement of the reducing activity in serum at alkaline pH, provides an index of protein glycation. The reducing activity is expressed in equivalents of 1-deoxy-1-morpholinofructose (DMF) by direct comparison with the activity either of this synthetic compound or with a secondary protein standard calibrated against DMF. This study reports the influence of assay timing on the apparent serum fructosamine concentration. The kinetics of alkaline reducing activity in serum differed from that in both DMF and a secondary protein standard. When compared with DMF, activity in serum increased but decreased relative to the protein standard as the pre-incubation interval of the assay was shortened. The use of secondary protein standards results in underestimation of serum fructosamine concentrations when the pre-incubation phase of the assay is shorter than that used for the calibration of the secondary standard. Ascorbate exerted an inhibitory effect in fructosamine assays with pre-incubation times exceeding 5 min. The inhibition increased with both the concentration of ascorbate and the duration of the pre-incubation.
Frandsen
E K
EK
Department of Pathology, Riyadh Armed Forces Hospital, Kingdom of Saudi Arabia.
Bacchus
R A
RA
D001205:Ascorbic Acid / Q000097:blood; D019270:Fructosamine; D006595:Hexosamines / Q000097:blood*; D006801:Humans; D006863:Hydrogen-Ion Concentration; D011933:Reagent Kits, Diagnostic; D013997:Time Factors
D006595:Hexosamines; D011933:Reagent Kits, Diagnostic; D019270:Fructosamine; D001205:Ascorbic Acid